Over Half of Post-COVID Vaccine Myocarditis Patients Still Had Symptoms After 6 Months: Study

Females were found to be ‘significantly more likely’ to have ongoing symptoms.
Over Half of Post-COVID Vaccine Myocarditis Patients Still Had Symptoms After 6 Months: Study
An illustration of the heart muscle. (Kateryna Kon/Shutterstock)
Naveen Athrappully
12/29/2023
Updated:
12/29/2023
0:00

A majority of people affected by heart conditions such as myocarditis after receiving COVID-19 shots were still suffering from the symptoms six months after the illnesses were diagnosed, according to a recent Australian study.

The peer-reviewed study, published in the journal Vaccine on Dec. 27, looked at two adverse events of special interest (AESI) post COVID-19 vaccination: myocarditis and myopericarditis. Myocarditis refers to the inflammation of a heart muscle called the myocardium, while myopericarditis is a condition in which the myocardium and the pericardium—the heart’s protective sac—are inflamed.

The study collected surveys from affected individuals at one, three, and six months following the onset of symptoms. Researchers found that at six months, 54.8 percent of survey respondents had ongoing symptoms of the two illnesses.

“At all follow-up time points, females were significantly more likely to have ongoing symptoms,” researchers wrote.

The study found that 51.9 percent of male respondents reported that their symptoms had resolves, compared to just 22.6 percent of female respondents.

“Females were also more likely to continue medication and have ongoing exercise restrictions,” it said. “However, males were significantly more likely to have higher initial peak troponin results and abnormal initial cardiac imaging investigations.”

Troponin is a protein in the blood that usually remains inside the cells of the heart muscle. However, damage to the cells can cause troponin to leak into the bloodstream. High levels of troponin can thus suggest heart damage.

“Male patients were more likely to report earlier and more complete symptom recovery, despite significantly higher average initial peak troponin,” the study observed.

The survey responses were received between Feb. 22, 2021, and Sept. 30, 2022, with the study conducted in Victoria, Australia.

Other Supporting Studies

Researchers pointed to evidence from other studies suggesting that people with myocarditis associated with COVID-19 vaccines tend to recover quickly. One study showed that 81 percent of such patients were deemed to have recovered within 90 days after being diagnosed.

However, “even though initial symptoms may resolve quickly, underlying changes on imaging investigations such as [edema], non-ischaemic late gadolinium enhancement (LGE), and hypokinesia have been noted in some COVID-19 vaccine myocarditis cases,” the authors noted.

“This may be a marker of significant myocardial injury, necrosis, scarring, or fibrosis and may result in long term morbidity.”

Edema refers to the build-up of fluids in the body, resulting in swollen tissues. LGE is a technique used in cardiac MRI for the assessment of myocardial scars. Hypokinesia refers to a type of movement disorder.

Researchers called for more analysis and long-term surveillance of myocarditis cases to understand the persistence of abnormalities and symptoms, including any potential development of heart failure or other cardiac comorbidities.

Authors of the study declared no known competing financial interests or personal relationships that could have impacted the study.

Myocarditis Risk From Vaccination

Several studies have shown myocarditis among individuals who were vaccinated against COVID-19. A July 25 study from Denmark looked at more than 2.2 million adults aged 50 years and above who received three COVID-19 vaccine doses.

After a fourth dose of the mRNA vaccine, researchers observed nine cases of myocarditis and 22 cases of pericarditis within 28 days of vaccination.

An August study published in Acta Paediatrica looked at 52,720 U.S. pediatric reports of adverse events post COVID-19 vaccination. It found that 567 individual cases of myocarditis were submitted to the Vaccine Adverse Event Reporting System (VAERS) among children who had received Pfizer’s mRNA vaccine.
“Our study showed that most of the cases of myocarditis occurred in males,” the authors wrote, adding that this was in line with a previous study conducted by Oster et al., which showed that 82 percent of the cases involved males.

“In addition, comparing our findings with those of Oster et al., we can reiterate that the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was highest after the second vaccination dose in adolescent males.”

A German study published on Nov. 27 looked at 25 people who died “unexpectedly” at their homes within 20 days of receiving a COVID-19 vaccine. Researchers identified myocarditis among five of the dead individuals.

All five took a Pfizer or Moderna vaccine within seven days of their deaths. None of them were infected with COVID-19.

For three out of the five individuals, COVID-19 vaccination was cited as the “likely cause” of myocarditis, with the condition blamed to be the “cause of sudden death.” The remaining two cases were attributed as deaths possibly caused by vaccination.

Empty COVID-19 vaccine vials at a vaccination center in Rosenheim, Germany, on April 20, 2021. (Christof Stache/AFP via Getty Images)
Empty COVID-19 vaccine vials at a vaccination center in Rosenheim, Germany, on April 20, 2021. (Christof Stache/AFP via Getty Images)

Dr. Andrew Bostom, a heart expert based in Rhode Island, told The Epoch Times that these cases were “the tip of the iceberg.”

“If there’s a seemingly healthy person that dies suddenly in their sleep, essentially, these are typically the cases that are autopsied, and clearly the most common finding is some form of atherosclerotic coronary heart disease. But they basically ruled that out in these cases. And then they came up with the most plausible proximate cause being vaccination,” he said.

“And so it suggests that the phenomenon could actually be broader than it’s been suspected to be.”

In September, the Florida Department of Health issued guidance on COVID-19 boosters, warning people to be aware of “safety and efficacy concerns,” including myocarditis.

“The mRNA COVID-19 vaccines present a risk of subclinical and clinical myocarditis and other cardiovascular conditions among otherwise healthy individuals,” the guidance said.

According to a peer-reviewed Japanese study, published in the Cureus journal on Dec. 7, about 70 percent of people who died in Japan after receiving a Pfizer COVID-19 vaccine lost their lives within the first 10 days following the jab.

The most common causes of death were heart-related issues.

Zachary Stieber contributed to this report.
Naveen Athrappully is a news reporter covering business and world events at The Epoch Times.
Related Topics